CALLSAS Study: Effect of Continuous Positive Airway Pressure Treatment for Obstructive Apnea on Phone Usage Habits (CALLSAS)

May 17, 2022 updated by: University Hospital, Grenoble

Effect of Continuous Positive Airway Pressure Treatment for Obstructive Apnea on Phone Usage Habits: the Callsas Study

Continuous positive airway pressure (CPAP) treatment improves sleepiness, depression and social activities in patients with obstructive sleep apnea (OSA). This evolution can be captured from changes in phone usage habits coupled with a mobile-based services. The aim of this study is to assess the impact of CPAP treatment on phone usage habits in OSA patients.

Study Overview

Status

Terminated

Intervention / Treatment

Detailed Description

Callsas is a prospective study embarking newly diagnosed obstructive sleep apnea patients initiated to CPAP treatment.

The primary objective is to analyze the modifications in phone usage habits before and after CPAP treatment.

Secondary objectives:

  • Correlation between changes in phone usage habits and evolution of sleepiness
  • Correlation between changes in phone usage habits and evolution of depression scale
  • Correlation between changes in phone usage habits and evolution of quality of life
  • Correlation between changes in physical activity measured by phones and evolution of physical activity objectively measured by actigraphy and gait platform
  • Correlation between phone usage habits and CPAP adherence

Study Type

Interventional

Enrollment (Actual)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rhône Alpes
      • Grenoble, Rhône Alpes, France, 38000
        • Grenoble Alps University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Newly diagnosed OSA patients initiated on CPAP
  • Follow-up at home by AGIR à dom
  • Customers of Orange (or Sosh) for mobile and/or fixed-line telephony for at least 6 months
  • Patient who signed a written consent to participate in the study
  • Patient affiliated to social security

Exclusion Criteria:

  • Pregnant women
  • Patients with disease not allowing to realize functional and locomotion tests
  • Person deprived of liberty by judicial or administrative decision, person subject to a legal protection measure (patient under guardianship or curatorship)
  • Patient who, in the judgment of the investigator, may not be cooperative or respectful of the obligations inherent to participation in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: CPAP treatment
All included OSA patients are going to be treated by CPAP
All patients included will be treated by CPAP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effect of CPAP on phone usage habits indices
Time Frame: from 6 months before CPAP treatment until 6 months after CPAP treatment initiation
Changes in indices of phone usage habits
from 6 months before CPAP treatment until 6 months after CPAP treatment initiation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time course evolution of phone usage habits indices and evolution of sleepiness
Time Frame: from CPAP initiation until 6 months after CPAP treatment initiation
Assessment of sleepiness by ESS
from CPAP initiation until 6 months after CPAP treatment initiation
Time course evolution of phone usage habits indices and evolution of depression
Time Frame: from CPAP initiation until 6 months after CPAP treatment initiation
Assessment of depression by Pichot scale
from CPAP initiation until 6 months after CPAP treatment initiation
Time course evolution of phone usage habits indices and evolution of quality of life
Time Frame: from CPAP initiation until 6 months after CPAP treatment initiation
Assessment of quality of life by SF-36
from CPAP initiation until 6 months after CPAP treatment initiation
Time course evolution of phone usage habits indices and evolution of locomotion
Time Frame: from CPAP initiation until 6 months after CPAP treatment initiation
patterns of locomotion objectively measured by a gait platform
from CPAP initiation until 6 months after CPAP treatment initiation
CPAP adherence
Time Frame: from CPAP initiation until 6 months after CPAP treatment initiation
Time course evolution of CPAP adherence assessed by telemonitoring versus time course evolution of phone usage habits
from CPAP initiation until 6 months after CPAP treatment initiation
Access to care as a predictor of CPAP adherence
Time Frame: from CPAP initiation until 6 months after CPAP treatment initiation
Care access questionnaire developed by ODENORE and National French insurance
from CPAP initiation until 6 months after CPAP treatment initiation
Effect of food habit with CPAP treatment
Time Frame: At CPAP initiation and at 6 months after CPAP treatment initiation
Changes in food frequence questionnaire
At CPAP initiation and at 6 months after CPAP treatment initiation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jean-Louis PEPIN, CHU Grenoble Alpes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 10, 2018

Primary Completion (Actual)

October 10, 2018

Study Completion (Actual)

June 15, 2021

Study Registration Dates

First Submitted

March 28, 2018

First Submitted That Met QC Criteria

May 14, 2018

First Posted (Actual)

May 25, 2018

Study Record Updates

Last Update Posted (Actual)

May 24, 2022

Last Update Submitted That Met QC Criteria

May 17, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Apnea, Obstructive

Clinical Trials on CPAP

3
Subscribe